These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34978519)

  • 21. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
    Liu G; Wang P; Zhang H
    J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
    Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
    Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C; Li X; Fan Q; Liu G; Yin J
    Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MEF2C and miR-194-5p: New Players in Triple Negative Breast Cancer Tumorigenesis.
    Caetano S; Garcia AR; Figueira I; Brito MA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway.
    Zan X; Li W; Wang G; Yuan J; Ai Y; Huang J; Li Z
    Reprod Biol Endocrinol; 2022 Sep; 20(1):138. PubMed ID: 36109751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0041732 regulates tumor properties of triple-negative breast cancer cells by the miR-149-5p/FGF5 pathway.
    Li H; Yin H; Yan Y
    Int J Biol Markers; 2022 Jun; 37(2):178-190. PubMed ID: 35341378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer.
    Ma S; Wei H; Wang C; Han J; Chen X; Li Y
    Cell Mol Biol Lett; 2021 Dec; 26(1):52. PubMed ID: 34895159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
    Liu F; Zhuang L; Wu R; Li D
    J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer.
    Zhang X; Li F; Zhou Y; Mao F; Lin Y; Shen S; Li Y; Zhang S; Sun Q
    Cell Death Dis; 2021 Jun; 12(7):627. PubMed ID: 34145213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer.
    Yan M; Li X; Tong D; Han C; Zhao R; He Y; Jin X
    Oncol Rep; 2016 Jul; 36(1):65-71. PubMed ID: 27108696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
    Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
    Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer.
    Li W; Liu C; Zhao C; Zhai L; Lv S
    Int J Oncol; 2016 Mar; 48(3):1155-64. PubMed ID: 26781040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
    Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
    Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib.
    Jonas K; Prinz F; Ferracin M; Krajina K; Pasculli B; Deutsch A; Madl T; Rinner B; Slaby O; Klec C; Pichler M
    Breast Cancer Res; 2023 Oct; 25(1):119. PubMed ID: 37803350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer.
    Kong P; Chen L; Yu M; Tao J; Liu J; Wang Y; Pan H; Zhou W; Wang S
    Cell Death Dis; 2018 Oct; 9(11):1059. PubMed ID: 30333478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.
    Wang Z; Wang X
    J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer.
    Son D; Kim Y; Lim S; Kang HG; Kim DH; Park JW; Cheong W; Kong HK; Han W; Park WY; Chun KH; Park JH
    Cancer Lett; 2019 Jul; 454():224-233. PubMed ID: 31004703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.